FDA OKs new clinical trial for EnteroMedics anti-obesity device

Let’s do it again.EnteroMedics Inc., based in Roseville, Minnesota, said Monday that the Food and Drug Administration has approved a new clinical trial for its Maestro anti-obesity device that uses electricity to suppress hunger.The news represents a major victory for EnteroMedics whose previous study ended in failure. Last October, initial results from the EMPOWER studies [...]

[Read more of this report]


Subscribe to
MedCity News' e-newsletter

SHS MD

MedCity News
Jobs Board

Get the Flash Player to see the wordTube Media Player.
Real Time Web Analytics